Zobrazeno 1 - 10
of 2 546
pro vyhledávání: '"Liver fat"'
Autor:
Hanna Frostdahl, Nouman Ahmad, Ulf Hammar, Andrés Martínez Mora, Taro Langner, Tove Fall, Joel Kullberg, Håkan Ahlström, Hannah L. Brooke, Shafqat Ahmad
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Genetic variants associated with increased liver fat and volume have been reported, but whether physical activity (PA) can attenuate the impact of genetic susceptibility to these traits is poorly understood. We aimed to investigate whether h
Externí odkaz:
https://doaj.org/article/b644cc4dfae245688d933c22ff2fc589
Autor:
Liuhong Zhu, Funan Wang, Heqing Wang, Jinhui Zhang, Anjie Xie, Jinkui Pei, Jianjun Zhou, Hao Liu
Publikováno v:
BMC Medical Imaging, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background In recent years, spectral CT-derived liver fat quantification method named multi-material decomposition (MMD) is playing an increasingly important role as an imaging biomarker of hepatic steatosis. However, there are various measu
Externí odkaz:
https://doaj.org/article/5a2ce6f5957643d49f76020cee1cced1
Publikováno v:
Autophagy Reports, Vol 3, Iss 1 (2024)
Beiging of adipocytes is characteristic of a higher number of mitochondria, the central hub of metabolism in the cell. However, studies show that beiging can improve metabolic health or cause metabolic disorders. Here we discuss a liver-fat crosstalk
Externí odkaz:
https://doaj.org/article/d03c361b368b4e0ab349e0d0c20093fb
Publikováno v:
Skeletal Muscle, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Aims Cross-sectional studies have demonstrated the association of skeletal muscle mass with metabolic-associated fatty liver disease (MAFLD), while longitudinal data are scarce. We aimed to explore the impact of changes in relative skeletal
Externí odkaz:
https://doaj.org/article/87af9e068e7d4ac08e21ed9ccfef156f
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 6, Pp 2908-2915 (2023)
Abstract Background Myosteatosis and liver steatosis (LS) have been recognized as patient‐derived image biomarkers that correlate with prognosis in colorectal cancer (CRC) patients. However, the significance of considering fat deposition in multipl
Externí odkaz:
https://doaj.org/article/83fa5566b0104889972324ba800a5a4c
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 11, Pp 01-05 (2023)
Introduction: Non Alcoholic Fatty Liver Disease (NAFLD) is one of the major leading causes of liver diseases, comprising a spectrum of conditions ranging from simple steatosis to cirrhosis. In the era of preventive medicine, it is of utmost impor
Externí odkaz:
https://doaj.org/article/dc8ee35fd8104347b40b1b489d0a1de8
Publikováno v:
Animals, Vol 14, Iss 14, p 2039 (2024)
In order to understand the intervention effect of taurine on liver fat deposition induced by high fat intake in the orange-spotted grouper (Epinephelus coioides), we performed proteomic analysis and association analysis with previously obtained trans
Externí odkaz:
https://doaj.org/article/0b9a172748604b12aab1665cf853bc52
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102248- (2023)
Summary: Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as increased liver fat percentage, and is the most common chronic liver disease in children. Rather than NAFLD, Metabolic-Associated Fatty Liver Disease (MAFLD), defined as inc
Externí odkaz:
https://doaj.org/article/2aaf1e0854944434907d2eefdddb0705
Autor:
Cristina Garcia-Beltran, Rita Malpique, Marianne S. Andersen, Firdevs Bas, Judit Bassols, Feyza Darendeliler, Marta Díaz, Barbara Dieris, Flaminia Fanelli, Elke Fröhlich-Reiterer, Alessandra Gambineri, Dorte Glintborg, Abel López-Bermejo, Christopher Mann, Silvia Marin, Barbara Obermayer-Pietsch, Rønnaug Ødegård, Pernille Ravn, Thomas Reinehr, Matteo Renzulli, Cristina Salvador, Viola Singer, Eszter Vanky, Juan Vicente Torres, Melek Yildiz, Francis de Zegher, Lourdes Ibáñez
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-25 (2023)
Abstract Background Polycystic ovary syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affecting 5–10% of AYAs worldwide. There is no approved pharmacological therapy for PCOS. Standa
Externí odkaz:
https://doaj.org/article/cd01e82c8557468c8c62a5200d948371
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.